Deutsche Bank AG Raises Stock Holdings in The Chemours Company (NYSE:CC)

Deutsche Bank AG lifted its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 74.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 86,029 shares of the specialty chemicals company's stock after buying an additional 36,823 shares during the period. Deutsche Bank AG owned about 0.06% of Chemours worth $1,454,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of CC. Norges Bank acquired a new position in Chemours in the 4th quarter worth about $30,702,000. Bank of Montreal Can increased its holdings in Chemours by 1,496.4% in the 4th quarter. Bank of Montreal Can now owns 953,240 shares of the specialty chemicals company's stock worth $16,110,000 after purchasing an additional 893,530 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in Chemours by 23.8% in the 4th quarter. Ameriprise Financial Inc. now owns 4,373,172 shares of the specialty chemicals company's stock worth $73,907,000 after purchasing an additional 839,849 shares in the last quarter. Invesco Ltd. increased its holdings in Chemours by 141.5% in the 4th quarter. Invesco Ltd. now owns 1,020,001 shares of the specialty chemicals company's stock worth $17,238,000 after purchasing an additional 597,638 shares in the last quarter. Finally, Covalis Capital LLP acquired a new position in Chemours in the 4th quarter worth about $8,768,000. Institutional investors and hedge funds own 76.26% of the company's stock.

Chemours Trading Up 3.0%

Shares of Chemours stock traded up $0.31 on Tuesday, hitting $10.61. 3,776,394 shares of the company's stock traded hands, compared to its average volume of 2,098,482. The Chemours Company has a one year low of $9.33 and a one year high of $26.98. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92. The company has a fifty day moving average of $11.88 and a two-hundred day moving average of $15.89. The company has a market capitalization of $1.59 billion, a price-to-earnings ratio of 18.61 and a beta of 1.76.

Chemours (NYSE:CC - Get Free Report) last announced its earnings results on Tuesday, May 6th. The specialty chemicals company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.06). The business had revenue of $1.37 billion for the quarter, compared to the consensus estimate of $1.36 billion. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The firm's revenue for the quarter was up .4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.32 EPS. As a group, sell-side analysts expect that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Dividend Announcement

The company also recently declared a dividend, which will be paid on Monday, June 16th. Shareholders of record on Monday, May 19th will be issued a $0.0875 dividend. The ex-dividend date is Friday, May 16th. This represents a yield of 3.17%. Chemours's payout ratio is currently 175.00%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CC shares. Wall Street Zen cut Chemours from a "hold" rating to a "sell" rating in a report on Wednesday, May 21st. Morgan Stanley decreased their price target on Chemours from $22.00 to $15.00 and set an "equal weight" rating for the company in a research note on Monday, May 12th. Mizuho set a $15.00 price target on Chemours in a research note on Tuesday, April 15th. Barclays decreased their price target on Chemours from $19.00 to $16.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 1st. Finally, BMO Capital Markets decreased their price target on Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a research note on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $17.56.

Insiders Place Their Bets

In related news, CFO Shane Hostetter bought 4,450 shares of the company's stock in a transaction dated Monday, May 19th. The shares were bought at an average price of $11.28 per share, for a total transaction of $50,196.00. Following the completion of the acquisition, the chief financial officer now directly owns 59,694 shares of the company's stock, valued at $673,348.32. This trade represents a 8.06% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.47% of the company's stock.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.